Biotronik launches BioMonitor 2 remote monitoring device in Europe

Biotronik has announced the European launch of BioMonitor 2, its new continuous and reliable arrhythmia monitoring system.

The new subcutaneous, insertable cardiac remote monitor is designed to be easy to insert and offers accurate arrhythmia detection and reliable home monitoring transmission. It is available in two versions, one specialised for atrial fibrillation detection and the other designed to help diagnose the cause of unexplained syncope.

A recent Australian pilot study showed a greater than 90 percent transmission reliability rate for daily Biotronik Home Monitoring transmissions, which exceeds industry standards. 

Additionally, the device has also been shown to have a capacity of over 60 minutes of ECG recording time and can transmit up to six subcutaneous ECG results daily via Home Monitoring.

Dr Christian Butter, head physician of the cardiology department at the Heart Centre Brandenburg, said: "BioMonitor 2 can take less than two minutes to insert, and it is a very easy procedure."

This comes after the firm launched a next-generation iteration of its Galeo coronary guidewires in Europe last month.